References
Alexander, P. Fetoprotein ‘antigens’ in cancer. Nature 235:137–139; 1972.
Belanger, L.; Hamel, D.; Lachance, L., et al. Hormonal regulation of α1 fetoprotein. Nature 256:657–659; 1975.
Darzynkiewicz, Z.; Bruno, S.; Del Bino, G., et al. Features of apoptosis cells measured by flow cytometry. Cytometry 13:795–808; 1992.
Dattwyler, R. J.; Murgita, R. A.; Tomasi, T. B. Binding of α-fetoprotein to murine T cells. Nature 256:656–657; 1975.
Gewirtz, A. M.; Calabretta, B. A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro. Science 242:1303–1306; 1988.
Laderoute, M. P.; Pilarski, L. M. The inhibition of apoptosis by alpha-fetoprotein (AFP) and the role of AFP receptors in anticellular senescence. Anticancer Res. 14:2429–2438; 1994.
Morinaga, T.; Sakai, M.; Wegmann, T. G., et al. Primary structures of human alpha-fetoprotein and its mRNA. Proc. Natl. Acad. Sci. USA 80:4604–4608; 1983.
Murgita, R. A.; Goidl, E. A.; Kontiainen, S., et al. α-Fetoprotein induces suppressor T cells in vitro. Nature 267:257–259; 1977.
Wang, X. W.; Xie, H. Significance of alpha-fetoprotein in the development of new therapeutic agents. Drugs Future 23; in press.
Wang, X. W.; Xu, B. Anti-alpha-fetoprotein activity of l-4-oxalysine. Asia Pacific J. Pharmacol. 11:25–28; 1996.
Wang, X. W.; Xu, B. Effect of l-4-oxalysine on alpha-fetoprotein gene expression in human BEL-7404 hepatoma cells. Asia Pacific J. Pharmacol. 12:37–40; 1997.
Wang, X. W.; Xu, B. Expression of alpha-fetoprotein messenger RNA in BEL-7404 human hepatoma cells and effect of l-4-oxalysine on the expression. World J. Gastroenterol. 4:294–297; 1998.
Wang, X. W.; Xu, B. Immunoregulatory activities of l-4-oxalysine: an in vitro study. Methods Find. Exp. Clin. Pharmacol. 19:437–442; 1997.
Wang, X. W.; Xu, B. Immunostimulatory action of l-4-oxalysine counteracts immunosuppression induced by alpha-fetoprotein. Eur. J. Pharmacol. 351:105–111; 1998.
Wang, X. W.; Xu, B. Mechanisms of antitumor action of l-4-oxalysine, a new natural product. Med. Chem. Res. 6:233–247; 1996.
Wang, X. W.; Xu, B. l-4-oxalysine: its antitumor activities and mechanisms of action. Drugs Future 21:727–731; 1996.
Wang, X. W.; Xu, B. l-4-oxalysine a new antitumor agent of natural origin. Med. Chem. Res. 6:225–232; 1996.
Wang, X. W.; Xu, B. Several new targets of antitumor agents. Acta Pharmacol. Sin. 18:289–292; 1997.
Wang, X. W.; Xu, B. Stimulation of tumor-cell growth by alpha-fetoprotein. Int. J. Cancer 75:596–599; 1998.
Watson, P. H.; Pon, R. T.; Shiu, R. P. C. Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer. Cancer Res. 51:3996–4000; 1991.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wang, XW., Xie, H. Growth inhibition of human liver cancer cells by alpha-fetoprotein antisense strategy. In Vitro Cell.Dev.Biol.-Animal 35, 118–119 (1999). https://doi.org/10.1007/s11626-999-0012-x
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11626-999-0012-x